Association of polypharmacy with incidence of CKD: a retrospective cohort study.

Hiroshi KimuraKenichi TanakaHirotaka SaitoTsuyoshi IwasakiShuhei WatanabeSakumi KazamaMichio ShimabukuroKoichi AsahiTsuyoshi WatanabeJunichiro James Kazama

Published in: Clinical and experimental nephrology (2022)

Hyper-polypharmacy is associated with a higher risk of CKD and cardiovascular events.

Keyphrases

cardiovascular events
chronic kidney disease
coronary artery disease
cardiovascular disease
adverse drug
risk factors
emergency department